Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
TLPInvest™ is a multi-asset class investment firm founded in 2004 by Dave Bunning, who serves as its Chief Executive Officer and Chief Investment Officer. The firm is headquartered in Libertyville, Illinois, and has a rich history of investing in global public markets for over 30 years. Operating as a closely held personal investment firm, TLPInvest does not seek outside investors, which allows for a focused investment strategy aligned with its values.
The firm has evolved to encompass a diverse range of investment activities, including venture capital, private equity, and real estate. TLPInvest is committed to achieving positive economic, societal, and environmental outcomes through its investments and philanthropic initiatives. This commitment is reflected in their partnerships with both early- and late-stage innovators, as well as established institutions.
TLPInvest employs a dynamic investment strategy that is influenced by current and anticipated macroeconomic forces. The firm invests across various sectors, including biotech, healthcare, fintech, and energy, targeting opportunities at multiple stages such as Friends & Family, Angel, Pre-seed, Seed, Series A through F, Growth Equity, Pre-IPO, and IPO. This broad approach allows TLPInvest to adapt to changing market conditions and seize the right opportunities at the right time.
Investment checks vary depending on the stage and sector, with a focus on impactful innovations that align with their thesis of achieving positive societal and environmental outcomes. TLPInvest actively seeks partnerships with founders who share a commitment to these values, emphasizing the importance of collaboration in driving meaningful change.
TLPInvest has a diversified philanthropic portfolio that includes partnerships with both early- and late-stage innovators. One notable portfolio company is Abreos Biosciences, which focuses on developing innovative therapeutic medical treatments. TLPInvest has played a significant role in funding research that led to the first FDA-approved food allergy therapy, showcasing its commitment to impactful healthcare solutions.
The firm’s portfolio reflects its focus on sectors such as biotech and healthcare, where it seeks to support advancements that can lead to significant societal benefits. TLPInvest's involvement in these areas highlights its strategy of aligning financial investments with positive outcomes for communities and the environment.
Dave Bunning: Founder, Chief Executive Officer, Chief Investment Officer. Dave has a strong background in investment, having joined Citadel Investment Group in 1991 when AUM was less than $20 million. He left in 2004 as Principal, Head of Global Credit Trading, and Management Committee member, by which time Citadel's AUM exceeded $10 billion. His expertise lies in institutional credit and macroeconomic strategies, which he applies to TLPInvest's investment approach.
Founders should reach out to TLPInvest through a warm introduction, ideally from a mutual connection. When preparing a pitch deck, it is important to include a clear overview of the business model, market opportunity, and alignment with TLPInvest's mission. While there is no formal application process, TLPInvest values detailed presentations that demonstrate a strong understanding of the market and the potential for impact.
Response times can vary, but founders should expect a thorough review process given the firm's active investment strategy. Engaging with TLPInvest early in the fundraising process can enhance the likelihood of a successful partnership.
As of March 2026, TLPInvest has been actively involved in funding research and developing innovative therapeutic medical treatments, including the first FDA-approved food allergy therapy. The firm continues to maintain partnerships with both early- and late-stage innovators, indicating ongoing engagement in the venture capital space.
What are TLPInvest's investment criteria?
TLPInvest focuses on sectors such as biotech, healthcare, fintech, and energy. The firm invests at various stages, from Friends & Family to IPO, and seeks opportunities that align with its commitment to positive societal and environmental outcomes.
How can founders pitch to TLPInvest?
Founders interested in pitching to TLPInvest should prepare a detailed presentation that outlines their business model, market potential, and alignment with TLPInvest's values. While the firm does not have a formal application process, a warm introduction is preferred.
What makes TLPInvest different from traditional VCs?
TLPInvest operates as a closely held personal investment firm and does not seek outside investors. This structure allows for a more flexible investment approach and a focus on long-term impact rather than short-term returns.
What is TLPInvest's geographic focus?
The firm invests globally, with a particular emphasis on North America. This broad geographic scope enables TLPInvest to identify and capitalize on diverse investment opportunities.
What kind of support does TLPInvest provide to portfolio companies?
TLPInvest offers strategic support to its portfolio companies, leveraging its extensive experience in investment and innovation to foster growth and development. This includes mentorship and access to resources that can help startups scale effectively.
What is the typical check size for investments?
Check sizes vary depending on the stage of investment and the specific opportunity. TLPInvest is known for its flexibility in funding, adapting to the needs of the companies it supports.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.